ResultsIQ

ResultsIQ › Latest results › Gem Aromatics Limited

Gem Aromatics Limited Q2 FY26 results deck summary

NSE: GEMAROMA · BSE: 544491

Results deck of 13 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹89.5 cr (-20.2% YoY) and PAT -₹2.6 cr, impacted by US tariffs and GST revision; Dahej commissioning expected November 2025.

Key takeaways

  1. Guidance No forward guidance given; management optimistic about H2 FY26 with Dahej commissioning.
  2. Driver New Dahej facility with high-value products Citral, Phenol derivatives, and Cooling Agents expected to drive growth.
  3. Risk US tariff uncertainty led customers to reduce orders and limit purchases, affecting export volumes.

Original filing on BSE

Gem Aromatics Limited Q1 FY27 results

As filed: Revenue ₹98.9 cr (+12% year on year), EBITDA ₹3.3 cr (−79% year on year), PAT −₹7.9 cr (−198% year on year), EBITDA margin 3.4% (−1,000 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹112 cr, EBITDA ₹15.1 cr, PAT ₹11.9 cr, EBITDA margin 13.4%. Not scored. No result for the same quarter last year. Share price after the results: +10.9% in 29 days (Nifty 500: +2.4%).
  • Q3 FY26: Revenue ₹83.9 cr, EBITDA ₹7.6 cr, PAT ₹4.2 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: +28.9% in 30 days (Nifty 500: +2.8%).
  • Q2 FY26: Revenue ₹98.0 cr, EBITDA ₹5.0 cr, PAT ₹4.0 cr, EBITDA margin 5.1%. Not scored. No result for the same quarter last year. Share price after the results: −28.9% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹76.0 cr, EBITDA ₹10.0 cr, PAT ₹7.0 cr, EBITDA margin 13.2%. Not scored. No result for the same quarter last year. Share price after the results: −13.1% in 28 days (Nifty 500: +0.6%).

Past price moves after results do not indicate future moves. Not a recommendation.

Gem Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.